• レポートコード:QFJ1-5684 • 出版社/出版日:QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、96ページ • 納品方法:Eメール(納期:3日) • 産業分類:医薬品 |
Single User | ¥585,000 (USD3,900) | ▷ お問い合わせ |
Multi User | ¥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、C-X-Cケモカイン受容体タイプ2の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(DF-2755A、AZD-5069、PAC-G31P、SX-517、その他)、用途別市場規模(冠状動脈疾患、肝移植拒絶反応、前立腺がん、肺炎症、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。 ・市場概要 ・C-X-Cケモカイン受容体タイプ2の市場動向 ・企業の競争状況、市場シェア ・C-X-Cケモカイン受容体タイプ2の種類別市場規模と予測2016-2027(DF-2755A、AZD-5069、PAC-G31P、SX-517、その他) ・C-X-Cケモカイン受容体タイプ2の用途別市場規模と予測2016-2027(冠状動脈疾患、肝移植拒絶反応、前立腺がん、肺炎症、その他) ・C-X-Cケモカイン受容体タイプ2の北米市場規模2016-2027(アメリカ、カナダ) ・C-X-Cケモカイン受容体タイプ2の欧州市場規模2016-2027(ドイツ、フランス、イギリス等) ・C-X-Cケモカイン受容体タイプ2のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等) ・C-X-Cケモカイン受容体タイプ2の中南米市場規模2016-2027(メキシコ、ブラジル) ・C-X-Cケモカイン受容体タイプ2の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等) ・主要企業情報(AstraZeneca Plc、ChemoCentryx Inc、Dompe Farmaceutici SpA、GlaxoSmithKline Plc、Novartis AG、Syntrix Biosystems Inc) ・結論 |
Market Analysis and Insights: Global C-X-C Chemokine Receptor Type 2 Market
The global C-X-C Chemokine Receptor Type 2 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global C-X-C Chemokine Receptor Type 2 market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global C-X-C Chemokine Receptor Type 2 market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global C-X-C Chemokine Receptor Type 2 market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global C-X-C Chemokine Receptor Type 2 market.
Global C-X-C Chemokine Receptor Type 2 Scope and Market Size
C-X-C Chemokine Receptor Type 2 market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global C-X-C Chemokine Receptor Type 2 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
DF-2755A
AZD-5069
PAC-G31P
SX-517
Others
Segment by Application
Cornary Artery Disease
Liver Transplant Rejection
Prostate Cancer
Pulmonary Inflammation
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AstraZeneca Plc
ChemoCentryx Inc
Dompe Farmaceutici SpA
GlaxoSmithKline Plc
Novartis AG
Syntrix Biosystems Inc
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global C-X-C Chemokine Receptor Type 2 Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 DF-2755A
1.2.3 AZD-5069
1.2.4 PAC-G31P
1.2.5 SX-517
1.2.6 Others
1.3 Market by Application
1.3.1 Global C-X-C Chemokine Receptor Type 2 Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cornary Artery Disease
1.3.3 Liver Transplant Rejection
1.3.4 Prostate Cancer
1.3.5 Pulmonary Inflammation
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global C-X-C Chemokine Receptor Type 2 Market Perspective (2016-2027)
2.2 C-X-C Chemokine Receptor Type 2 Growth Trends by Regions
2.2.1 C-X-C Chemokine Receptor Type 2 Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 C-X-C Chemokine Receptor Type 2 Historic Market Share by Regions (2016-2021)
2.2.3 C-X-C Chemokine Receptor Type 2 Forecasted Market Size by Regions (2022-2027)
2.3 C-X-C Chemokine Receptor Type 2 Industry Dynamic
2.3.1 C-X-C Chemokine Receptor Type 2 Market Trends
2.3.2 C-X-C Chemokine Receptor Type 2 Market Drivers
2.3.3 C-X-C Chemokine Receptor Type 2 Market Challenges
2.3.4 C-X-C Chemokine Receptor Type 2 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top C-X-C Chemokine Receptor Type 2 Players by Revenue
3.1.1 Global Top C-X-C Chemokine Receptor Type 2 Players by Revenue (2016-2021)
3.1.2 Global C-X-C Chemokine Receptor Type 2 Revenue Market Share by Players (2016-2021)
3.2 Global C-X-C Chemokine Receptor Type 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by C-X-C Chemokine Receptor Type 2 Revenue
3.4 Global C-X-C Chemokine Receptor Type 2 Market Concentration Ratio
3.4.1 Global C-X-C Chemokine Receptor Type 2 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by C-X-C Chemokine Receptor Type 2 Revenue in 2020
3.5 C-X-C Chemokine Receptor Type 2 Key Players Head office and Area Served
3.6 Key Players C-X-C Chemokine Receptor Type 2 Product Solution and Service
3.7 Date of Enter into C-X-C Chemokine Receptor Type 2 Market
3.8 Mergers & Acquisitions, Expansion Plans
4 C-X-C Chemokine Receptor Type 2 Breakdown Data by Type
4.1 Global C-X-C Chemokine Receptor Type 2 Historic Market Size by Type (2016-2021)
4.2 Global C-X-C Chemokine Receptor Type 2 Forecasted Market Size by Type (2022-2027)
5 C-X-C Chemokine Receptor Type 2 Breakdown Data by Application
5.1 Global C-X-C Chemokine Receptor Type 2 Historic Market Size by Application (2016-2021)
5.2 Global C-X-C Chemokine Receptor Type 2 Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America C-X-C Chemokine Receptor Type 2 Market Size (2016-2027)
6.2 North America C-X-C Chemokine Receptor Type 2 Market Size by Type
6.2.1 North America C-X-C Chemokine Receptor Type 2 Market Size by Type (2016-2021)
6.2.2 North America C-X-C Chemokine Receptor Type 2 Market Size by Type (2022-2027)
6.2.3 North America C-X-C Chemokine Receptor Type 2 Market Size by Type (2016-2027)
6.3 North America C-X-C Chemokine Receptor Type 2 Market Size by Application
6.3.1 North America C-X-C Chemokine Receptor Type 2 Market Size by Application (2016-2021)
6.3.2 North America C-X-C Chemokine Receptor Type 2 Market Size by Application (2022-2027)
6.3.3 North America C-X-C Chemokine Receptor Type 2 Market Size by Application (2016-2027)
6.4 North America C-X-C Chemokine Receptor Type 2 Market Size by Country
6.4.1 North America C-X-C Chemokine Receptor Type 2 Market Size by Country (2016-2021)
6.4.2 North America C-X-C Chemokine Receptor Type 2 Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe C-X-C Chemokine Receptor Type 2 Market Size (2016-2027)
7.2 Europe C-X-C Chemokine Receptor Type 2 Market Size by Type
7.2.1 Europe C-X-C Chemokine Receptor Type 2 Market Size by Type (2016-2021)
7.2.2 Europe C-X-C Chemokine Receptor Type 2 Market Size by Type (2022-2027)
7.2.3 Europe C-X-C Chemokine Receptor Type 2 Market Size by Type (2016-2027)
7.3 Europe C-X-C Chemokine Receptor Type 2 Market Size by Application
7.3.1 Europe C-X-C Chemokine Receptor Type 2 Market Size by Application (2016-2021)
7.3.2 Europe C-X-C Chemokine Receptor Type 2 Market Size by Application (2022-2027)
7.3.3 Europe C-X-C Chemokine Receptor Type 2 Market Size by Application (2016-2027)
7.4 Europe C-X-C Chemokine Receptor Type 2 Market Size by Country
7.4.1 Europe C-X-C Chemokine Receptor Type 2 Market Size by Country (2016-2021)
7.4.2 Europe C-X-C Chemokine Receptor Type 2 Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific C-X-C Chemokine Receptor Type 2 Market Size (2016-2027)
8.2 Asia-Pacific C-X-C Chemokine Receptor Type 2 Market Size by Type
8.2.1 Asia-Pacific C-X-C Chemokine Receptor Type 2 Market Size by Type (2016-2021)
8.2.2 Asia-Pacific C-X-C Chemokine Receptor Type 2 Market Size by Type (2022-2027)
8.2.3 Asia-Pacific C-X-C Chemokine Receptor Type 2 Market Size by Type (2016-2027)
8.3 Asia-Pacific C-X-C Chemokine Receptor Type 2 Market Size by Application
8.3.1 Asia-Pacific C-X-C Chemokine Receptor Type 2 Market Size by Application (2016-2021)
8.3.2 Asia-Pacific C-X-C Chemokine Receptor Type 2 Market Size by Application (2022-2027)
8.3.3 Asia-Pacific C-X-C Chemokine Receptor Type 2 Market Size by Application (2016-2027)
8.4 Asia-Pacific C-X-C Chemokine Receptor Type 2 Market Size by Region
8.4.1 Asia-Pacific C-X-C Chemokine Receptor Type 2 Market Size by Region (2016-2021)
8.4.2 Asia-Pacific C-X-C Chemokine Receptor Type 2 Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America C-X-C Chemokine Receptor Type 2 Market Size (2016-2027)
9.2 Latin America C-X-C Chemokine Receptor Type 2 Market Size by Type
9.2.1 Latin America C-X-C Chemokine Receptor Type 2 Market Size by Type (2016-2021)
9.2.2 Latin America C-X-C Chemokine Receptor Type 2 Market Size by Type (2022-2027)
9.2.3 Latin America C-X-C Chemokine Receptor Type 2 Market Size by Type (2016-2027)
9.3 Latin America C-X-C Chemokine Receptor Type 2 Market Size by Application
9.3.1 Latin America C-X-C Chemokine Receptor Type 2 Market Size by Application (2016-2021)
9.3.2 Latin America C-X-C Chemokine Receptor Type 2 Market Size by Application (2022-2027)
9.3.3 Latin America C-X-C Chemokine Receptor Type 2 Market Size by Application (2016-2027)
9.4 Latin America C-X-C Chemokine Receptor Type 2 Market Size by Country
9.4.1 Latin America C-X-C Chemokine Receptor Type 2 Market Size by Country (2016-2021)
9.4.2 Latin America C-X-C Chemokine Receptor Type 2 Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size (2016-2027)
10.2 Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Type
10.2.1 Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Type (2016-2021)
10.2.2 Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Type (2022-2027)
10.2.3 Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Type (2016-2027)
10.3 Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Application
10.3.1 Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Application (2016-2021)
10.3.2 Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Application (2022-2027)
10.3.3 Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Application (2016-2027)
10.4 Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Country
10.4.1 Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Country (2016-2021)
10.4.2 Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZeneca Plc
11.1.1 AstraZeneca Plc Company Details
11.1.2 AstraZeneca Plc Business Overview
11.1.3 AstraZeneca Plc C-X-C Chemokine Receptor Type 2 Introduction
11.1.4 AstraZeneca Plc Revenue in C-X-C Chemokine Receptor Type 2 Business (2016-2021)
11.1.5 AstraZeneca Plc Recent Development
11.2 ChemoCentryx Inc
11.2.1 ChemoCentryx Inc Company Details
11.2.2 ChemoCentryx Inc Business Overview
11.2.3 ChemoCentryx Inc C-X-C Chemokine Receptor Type 2 Introduction
11.2.4 ChemoCentryx Inc Revenue in C-X-C Chemokine Receptor Type 2 Business (2016-2021)
11.2.5 ChemoCentryx Inc Recent Development
11.3 Dompe Farmaceutici SpA
11.3.1 Dompe Farmaceutici SpA Company Details
11.3.2 Dompe Farmaceutici SpA Business Overview
11.3.3 Dompe Farmaceutici SpA C-X-C Chemokine Receptor Type 2 Introduction
11.3.4 Dompe Farmaceutici SpA Revenue in C-X-C Chemokine Receptor Type 2 Business (2016-2021)
11.3.5 Dompe Farmaceutici SpA Recent Development
11.4 GlaxoSmithKline Plc
11.4.1 GlaxoSmithKline Plc Company Details
11.4.2 GlaxoSmithKline Plc Business Overview
11.4.3 GlaxoSmithKline Plc C-X-C Chemokine Receptor Type 2 Introduction
11.4.4 GlaxoSmithKline Plc Revenue in C-X-C Chemokine Receptor Type 2 Business (2016-2021)
11.4.5 GlaxoSmithKline Plc Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Details
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG C-X-C Chemokine Receptor Type 2 Introduction
11.5.4 Novartis AG Revenue in C-X-C Chemokine Receptor Type 2 Business (2016-2021)
11.5.5 Novartis AG Recent Development
11.6 Syntrix Biosystems Inc
11.6.1 Syntrix Biosystems Inc Company Details
11.6.2 Syntrix Biosystems Inc Business Overview
11.6.3 Syntrix Biosystems Inc C-X-C Chemokine Receptor Type 2 Introduction
11.6.4 Syntrix Biosystems Inc Revenue in C-X-C Chemokine Receptor Type 2 Business (2016-2021)
11.6.5 Syntrix Biosystems Inc Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global C-X-C Chemokine Receptor Type 2 Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of DF-2755A
Table 3. Key Players of AZD-5069
Table 4. Key Players of PAC-G31P
Table 5. Key Players of SX-517
Table 6. Key Players of Others
Table 7. Global C-X-C Chemokine Receptor Type 2 Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global C-X-C Chemokine Receptor Type 2 Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global C-X-C Chemokine Receptor Type 2 Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global C-X-C Chemokine Receptor Type 2 Market Share by Regions (2016-2021)
Table 11. Global C-X-C Chemokine Receptor Type 2 Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global C-X-C Chemokine Receptor Type 2 Market Share by Regions (2022-2027)
Table 13. C-X-C Chemokine Receptor Type 2 Market Trends
Table 14. C-X-C Chemokine Receptor Type 2 Market Drivers
Table 15. C-X-C Chemokine Receptor Type 2 Market Challenges
Table 16. C-X-C Chemokine Receptor Type 2 Market Restraints
Table 17. Global C-X-C Chemokine Receptor Type 2 Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global C-X-C Chemokine Receptor Type 2 Market Share by Players (2016-2021)
Table 19. Global Top C-X-C Chemokine Receptor Type 2 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in C-X-C Chemokine Receptor Type 2 as of 2020)
Table 20. Ranking of Global Top C-X-C Chemokine Receptor Type 2 Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by C-X-C Chemokine Receptor Type 2 Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players C-X-C Chemokine Receptor Type 2 Product Solution and Service
Table 24. Date of Enter into C-X-C Chemokine Receptor Type 2 Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global C-X-C Chemokine Receptor Type 2 Market Size by Type (2016-2021) (US$ Million)
Table 27. Global C-X-C Chemokine Receptor Type 2 Revenue Market Share by Type (2016-2021)
Table 28. Global C-X-C Chemokine Receptor Type 2 Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global C-X-C Chemokine Receptor Type 2 Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global C-X-C Chemokine Receptor Type 2 Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global C-X-C Chemokine Receptor Type 2 Revenue Market Share by Application (2016-2021)
Table 32. Global C-X-C Chemokine Receptor Type 2 Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global C-X-C Chemokine Receptor Type 2 Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America C-X-C Chemokine Receptor Type 2 Market Size by Type (2016-2021) (US$ Million)
Table 35. North America C-X-C Chemokine Receptor Type 2 Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America C-X-C Chemokine Receptor Type 2 Market Size by Application (2016-2021) (US$ Million)
Table 37. North America C-X-C Chemokine Receptor Type 2 Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America C-X-C Chemokine Receptor Type 2 Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America C-X-C Chemokine Receptor Type 2 Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe C-X-C Chemokine Receptor Type 2 Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe C-X-C Chemokine Receptor Type 2 Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe C-X-C Chemokine Receptor Type 2 Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe C-X-C Chemokine Receptor Type 2 Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe C-X-C Chemokine Receptor Type 2 Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe C-X-C Chemokine Receptor Type 2 Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific C-X-C Chemokine Receptor Type 2 Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific C-X-C Chemokine Receptor Type 2 Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific C-X-C Chemokine Receptor Type 2 Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific C-X-C Chemokine Receptor Type 2 Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific C-X-C Chemokine Receptor Type 2 Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific C-X-C Chemokine Receptor Type 2 Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America C-X-C Chemokine Receptor Type 2 Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America C-X-C Chemokine Receptor Type 2 Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America C-X-C Chemokine Receptor Type 2 Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America C-X-C Chemokine Receptor Type 2 Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America C-X-C Chemokine Receptor Type 2 Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America C-X-C Chemokine Receptor Type 2 Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Country (2022-2027) & (US$ Million)
Table 64. AstraZeneca Plc Company Details
Table 65. AstraZeneca Plc Business Overview
Table 66. AstraZeneca Plc C-X-C Chemokine Receptor Type 2 Product
Table 67. AstraZeneca Plc Revenue in C-X-C Chemokine Receptor Type 2 Business (2016-2021) & (US$ Million)
Table 68. AstraZeneca Plc Recent Development
Table 69. ChemoCentryx Inc Company Details
Table 70. ChemoCentryx Inc Business Overview
Table 71. ChemoCentryx Inc C-X-C Chemokine Receptor Type 2 Product
Table 72. ChemoCentryx Inc Revenue in C-X-C Chemokine Receptor Type 2 Business (2016-2021) & (US$ Million)
Table 73. ChemoCentryx Inc Recent Development
Table 74. Dompe Farmaceutici SpA Company Details
Table 75. Dompe Farmaceutici SpA Business Overview
Table 76. Dompe Farmaceutici SpA C-X-C Chemokine Receptor Type 2 Product
Table 77. Dompe Farmaceutici SpA Revenue in C-X-C Chemokine Receptor Type 2 Business (2016-2021) & (US$ Million)
Table 78. Dompe Farmaceutici SpA Recent Development
Table 79. GlaxoSmithKline Plc Company Details
Table 80. GlaxoSmithKline Plc Business Overview
Table 81. GlaxoSmithKline Plc C-X-C Chemokine Receptor Type 2 Product
Table 82. GlaxoSmithKline Plc Revenue in C-X-C Chemokine Receptor Type 2 Business (2016-2021) & (US$ Million)
Table 83. GlaxoSmithKline Plc Recent Development
Table 84. Novartis AG Company Details
Table 85. Novartis AG Business Overview
Table 86. Novartis AG C-X-C Chemokine Receptor Type 2 Product
Table 87. Novartis AG Revenue in C-X-C Chemokine Receptor Type 2 Business (2016-2021) & (US$ Million)
Table 88. Novartis AG Recent Development
Table 89. Syntrix Biosystems Inc Company Details
Table 90. Syntrix Biosystems Inc Business Overview
Table 91. Syntrix Biosystems Inc C-X-C Chemokine Receptor Type 2 Product
Table 92. Syntrix Biosystems Inc Revenue in C-X-C Chemokine Receptor Type 2 Business (2016-2021) & (US$ Million)
Table 93. Syntrix Biosystems Inc Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global C-X-C Chemokine Receptor Type 2 Market Share by Type: 2020 VS 2027
Figure 2. DF-2755A Features
Figure 3. AZD-5069 Features
Figure 4. PAC-G31P Features
Figure 5. SX-517 Features
Figure 6. Others Features
Figure 7. Global C-X-C Chemokine Receptor Type 2 Market Share by Application: 2020 VS 2027
Figure 8. Cornary Artery Disease Case Studies
Figure 9. Liver Transplant Rejection Case Studies
Figure 10. Prostate Cancer Case Studies
Figure 11. Pulmonary Inflammation Case Studies
Figure 12. Others Case Studies
Figure 13. C-X-C Chemokine Receptor Type 2 Report Years Considered
Figure 14. Global C-X-C Chemokine Receptor Type 2 Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global C-X-C Chemokine Receptor Type 2 Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global C-X-C Chemokine Receptor Type 2 Market Share by Regions: 2020 VS 2027
Figure 17. Global C-X-C Chemokine Receptor Type 2 Market Share by Regions (2022-2027)
Figure 18. Global C-X-C Chemokine Receptor Type 2 Market Share by Players in 2020
Figure 19. Global Top C-X-C Chemokine Receptor Type 2 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in C-X-C Chemokine Receptor Type 2 as of 2020
Figure 20. The Top 10 and 5 Players Market Share by C-X-C Chemokine Receptor Type 2 Revenue in 2020
Figure 21. Global C-X-C Chemokine Receptor Type 2 Revenue Market Share by Type (2016-2021)
Figure 22. Global C-X-C Chemokine Receptor Type 2 Revenue Market Share by Type (2022-2027)
Figure 23. North America C-X-C Chemokine Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America C-X-C Chemokine Receptor Type 2 Market Share by Type (2016-2027)
Figure 25. North America C-X-C Chemokine Receptor Type 2 Market Share by Application (2016-2027)
Figure 26. North America C-X-C Chemokine Receptor Type 2 Market Share by Country (2016-2027)
Figure 27. United States C-X-C Chemokine Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada C-X-C Chemokine Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe C-X-C Chemokine Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe C-X-C Chemokine Receptor Type 2 Market Share by Type (2016-2027)
Figure 31. Europe C-X-C Chemokine Receptor Type 2 Market Share by Application (2016-2027)
Figure 32. Europe C-X-C Chemokine Receptor Type 2 Market Share by Country (2016-2027)
Figure 33. Germany C-X-C Chemokine Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France C-X-C Chemokine Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. C-X-C Chemokine Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy C-X-C Chemokine Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia C-X-C Chemokine Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic C-X-C Chemokine Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific C-X-C Chemokine Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific C-X-C Chemokine Receptor Type 2 Market Share by Type (2016-2027)
Figure 41. Asia-Pacific C-X-C Chemokine Receptor Type 2 Market Share by Application (2016-2027)
Figure 42. Asia-Pacific C-X-C Chemokine Receptor Type 2 Market Share by Region (2016-2027)
Figure 43. China C-X-C Chemokine Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan C-X-C Chemokine Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea C-X-C Chemokine Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia C-X-C Chemokine Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India C-X-C Chemokine Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia C-X-C Chemokine Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America C-X-C Chemokine Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America C-X-C Chemokine Receptor Type 2 Market Share by Type (2016-2027)
Figure 51. Latin America C-X-C Chemokine Receptor Type 2 Market Share by Application (2016-2027)
Figure 52. Latin America C-X-C Chemokine Receptor Type 2 Market Share by Country (2016-2027)
Figure 53. Mexico C-X-C Chemokine Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil C-X-C Chemokine Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Share by Type (2016-2027)
Figure 57. Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Share by Application (2016-2027)
Figure 58. Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Share by Country (2016-2027)
Figure 59. Turkey C-X-C Chemokine Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia C-X-C Chemokine Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE C-X-C Chemokine Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. AstraZeneca Plc Revenue Growth Rate in C-X-C Chemokine Receptor Type 2 Business (2016-2021)
Figure 63. ChemoCentryx Inc Revenue Growth Rate in C-X-C Chemokine Receptor Type 2 Business (2016-2021)
Figure 64. Dompe Farmaceutici SpA Revenue Growth Rate in C-X-C Chemokine Receptor Type 2 Business (2016-2021)
Figure 65. GlaxoSmithKline Plc Revenue Growth Rate in C-X-C Chemokine Receptor Type 2 Business (2016-2021)
Figure 66. Novartis AG Revenue Growth Rate in C-X-C Chemokine Receptor Type 2 Business (2016-2021)
Figure 67. Syntrix Biosystems Inc Revenue Growth Rate in C-X-C Chemokine Receptor Type 2 Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed